Simple Summary Hepatocellular carcinoma (HCC) is a global health challenge. Hepatitis
virus infection (including HBV, HCV and HDV) is one of the major risk factors for HCC …

Diabetic patients are frequently affected by coronary microvascular dysfunction (CMD), a
condition consisting of a combination of altered vasomotion and long-term structural change …

Direct-acting antivirals (DAAs) induce a rapid virologic response (SVR) in up to 99% of
chronic hepatitis C patients. The role of SVR by DAAs on the incidence or recurrence of …

Hepatocellular carcinoma (HCC) is one of the leading causes of death from cancer in the
world. Recently, the effectiveness of new antiviral therapies and the HBV vaccine have …

Background and aims Beyond type 2 diabetes, even a condition of prediabetes is
associated with an increased cardiovascular (CV) risk, and HCV infection coexistence …

Background & Aims Hepatitis C virus (HCV) eradication with direct-acting antivirals reduces
hepatocellular carcinoma (HCC) risk. Pooled HCC incidence rates by cirrhosis status and …

A high increase witnessed in type II diabetes mellitus (T2DM) globally has increasingly
posed a serious threat to global increases in liver cancer with the association between …

OBJECTIVE: To investigate the incidence of hepatocellular carcinoma (HCC) in Chengdu,
identify the risk factors for the development of HCC in Chengdu and provide a reference for …

The long‐term effects of direct‐acting antiviral therapies (DAAs) for chronic hepatitis C
(CHC) remain uncertain. The objective of this systematic review and meta‐analysis was to …

Hepatitis C infection is one of the main reasons for liver cirrhosis and hepatocellular
carcinoma. In recent years, more and more is being heard about extrahepatic manifestations …